Kailera Therapeutics annual free cash flow
2024
2025
2025
Kailera Therapeutics Free Cash Flow (FCF) History (KLRA)
Kailera Therapeutics reported −$122.3M in free cash flow for fiscal 2025.
View full Kailera Therapeutics company overviewKailera Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$122.3M | — | — | — |
| 2025 | 2025-05-08 | −$1.8M | −$1.6M | — | — |
| 2024 | 2024-05-08 | −$209,000 | — | — | — |
Kailera Therapeutics free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Kailera Therapeutics source filings ↗